Population
Patients with non-dystrophic myotonias (skeletal muscle channelopathies)
Design
Review
Authors
Loading...
Non-dystrophic myotonia treatment lacks standardization; leaves open optimal regimens until multi-center RCTs are completed.
This review highlights the molecular pathogenesis of non-dystrophic myotonias and emphasizes the need for multi-center randomized controlled trials to establish standard treatments.
Matthews et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: